PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10081494-0	1998	EAT/mcl-1, a member of the bcl-2 related genes, confers resistance to apoptosis induced by cis-diammine dichloroplatinum (II) via a p53-independent pathway.	Cisplatin	91-120	MCL1 apoptosis regulator, BCL2 family member	Homo sapiens	4-9	
10081494-0	1998	EAT/mcl-1, a member of the bcl-2 related genes, confers resistance to apoptosis induced by cis-diammine dichloroplatinum (II) via a p53-independent pathway.	Cisplatin	91-120	BCL2 apoptosis regulator	Homo sapiens	27-32	
10081494-0	1998	EAT/mcl-1, a member of the bcl-2 related genes, confers resistance to apoptosis induced by cis-diammine dichloroplatinum (II) via a p53-independent pathway.	Cisplatin	91-120	tumor protein p53	Homo sapiens	132-135	
10081494-3	1998	Cells transfected with EAT/mcl-1 showed higher resistance to cis-diammine dichloroplatinum (II) (CDDP) and carboplatin compared with the parental line (10)1 and neomycin-resistance gene-transfected clone, (10)1/neo.	Cisplatin	61-90	MCL1 apoptosis regulator, BCL2 family member	Homo sapiens	27-32	
10081494-3	1998	Cells transfected with EAT/mcl-1 showed higher resistance to cis-diammine dichloroplatinum (II) (CDDP) and carboplatin compared with the parental line (10)1 and neomycin-resistance gene-transfected clone, (10)1/neo.	Cisplatin	97-101	MCL1 apoptosis regulator, BCL2 family member	Homo sapiens	27-32	
10081494-3	1998	Cells transfected with EAT/mcl-1 showed higher resistance to cis-diammine dichloroplatinum (II) (CDDP) and carboplatin compared with the parental line (10)1 and neomycin-resistance gene-transfected clone, (10)1/neo.	Carboplatin	107-118	MCL1 apoptosis regulator, BCL2 family member	Homo sapiens	27-32	
10081494-3	1998	Cells transfected with EAT/mcl-1 showed higher resistance to cis-diammine dichloroplatinum (II) (CDDP) and carboplatin compared with the parental line (10)1 and neomycin-resistance gene-transfected clone, (10)1/neo.	Neomycin	161-169	MCL1 apoptosis regulator, BCL2 family member	Homo sapiens	27-32	
10081494-8	1998	Since CDDP and carboplatin damage DNA and then activate c-abl and the JNK/SAPK pathway, EAT/mcl-1 may inhibit p53-independent apoptosis through a c-abl/JNK (SAPK)-dependent mechanism.	Cisplatin	6-10	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	56-61	
10081494-8	1998	Since CDDP and carboplatin damage DNA and then activate c-abl and the JNK/SAPK pathway, EAT/mcl-1 may inhibit p53-independent apoptosis through a c-abl/JNK (SAPK)-dependent mechanism.	Cisplatin	6-10	mitogen-activated protein kinase 8	Homo sapiens	70-73	
10081494-8	1998	Since CDDP and carboplatin damage DNA and then activate c-abl and the JNK/SAPK pathway, EAT/mcl-1 may inhibit p53-independent apoptosis through a c-abl/JNK (SAPK)-dependent mechanism.	Cisplatin	6-10	MCL1 apoptosis regulator, BCL2 family member	Homo sapiens	92-97	
10081494-8	1998	Since CDDP and carboplatin damage DNA and then activate c-abl and the JNK/SAPK pathway, EAT/mcl-1 may inhibit p53-independent apoptosis through a c-abl/JNK (SAPK)-dependent mechanism.	Cisplatin	6-10	tumor protein p53	Homo sapiens	110-113	
10081494-8	1998	Since CDDP and carboplatin damage DNA and then activate c-abl and the JNK/SAPK pathway, EAT/mcl-1 may inhibit p53-independent apoptosis through a c-abl/JNK (SAPK)-dependent mechanism.	Cisplatin	6-10	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	146-151	
10081494-8	1998	Since CDDP and carboplatin damage DNA and then activate c-abl and the JNK/SAPK pathway, EAT/mcl-1 may inhibit p53-independent apoptosis through a c-abl/JNK (SAPK)-dependent mechanism.	Cisplatin	6-10	mitogen-activated protein kinase 8	Homo sapiens	152-155	
10081494-8	1998	Since CDDP and carboplatin damage DNA and then activate c-abl and the JNK/SAPK pathway, EAT/mcl-1 may inhibit p53-independent apoptosis through a c-abl/JNK (SAPK)-dependent mechanism.	Carboplatin	15-26	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	56-61	
10081494-8	1998	Since CDDP and carboplatin damage DNA and then activate c-abl and the JNK/SAPK pathway, EAT/mcl-1 may inhibit p53-independent apoptosis through a c-abl/JNK (SAPK)-dependent mechanism.	Carboplatin	15-26	mitogen-activated protein kinase 8	Homo sapiens	70-73	
10081494-8	1998	Since CDDP and carboplatin damage DNA and then activate c-abl and the JNK/SAPK pathway, EAT/mcl-1 may inhibit p53-independent apoptosis through a c-abl/JNK (SAPK)-dependent mechanism.	Carboplatin	15-26	MCL1 apoptosis regulator, BCL2 family member	Homo sapiens	92-97